Skip to main content
hello world

Closing Bell: Arch Biopartners Inc up on Tuesday (ARCH)

Automated Summaries - The Globe and Mail - Tue Jul 30, 4:02PM CDT

Arch Biopartners Inc opened trading today at $1.60 and closed at $1.57. prices ranged from $1.55 to $1.60.

The price gained 0.64 percent from the previous day's close of $1.56.

Today across North America, the TSX Composite closed 0.20% at 22824.67, the S&P 500 closed 0.08% at 5463.54, the Dow Jones Industrial Average closed -0.12% at 40539.93 and the Nasdaq Composite closed 0.07% at 17370.20.

Arch Biopartners Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker ARCH.

A total of 17,612 shares was traded during the session, with total trades of 42. On average, Arch Biopartners Inc has traded 25,022 shares in the last five days and 23,010 year-to-date.

The TSX-V overall saw 2,584 price advancers against 2,644 declines and 86 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, in the last 12 months, Arch Biopartners Inc's shares have dipped -25.24 percent, while they have advanced 6.08% this year.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $99.61 million on a float of 63,851 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Arch Biopartners Inc is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..